Literature DB >> 22842848

A case of Epstein-Barr virus-related lymphadenopathy mimicking the clinical features of IgG4-related disease.

Yoko Wada1, Masaru Kojima, Kazuhiro Yoshita, Mihoko Yamazaki, Daisuke Kobayashi, Shuichi Murakami, Shinichi Nishi, Masaaki Nakano, Ichiei Narita.   

Abstract

We report an intriguing case of Epstein-Barr virus (EBV)-related multiple lymphadenopathy that clinically mimics immunoglobulin G4-related disease (IgG4-RD). A 72-year-old woman presented with a history of asthma attacks, systemic lymphadenopathy, hypergammaglobulinemia, proteinuria, and an elevated level of serum IgG4, leading to a possible diagnosis of IgG4-RD based on current comprehensive diagnostic criteria. However, a percutaneous kidney biopsy specimen showed mild mesangial proliferative glomerulonephritis with focal membranous transformation, and there was no interstitial lesion or lymphocyte infiltration. Cervical lymph node biopsy demonstrated follicular hyperplasia associated with prominent lymphoplasmacytic infiltration in the interfollicular area. However, only a few IgG4-positive plasma cells were present. An in situ hybridization study demonstrated many EBV-infected lymphocytes in the germinal center as well as in the interfollicular area. This case illustrates the diversity of conditions associated with elevated levels of serum IgG4 and the necessity for tissue biopsy when diagnosing IgG4-RD.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22842848     DOI: 10.1007/s10165-012-0695-9

Source DB:  PubMed          Journal:  Mod Rheumatol        ISSN: 1439-7595            Impact factor:   3.023


  2 in total

1.  False-positive serologies for acute hepatitis A and autoimmune hepatitis in a patient with acute Epstein-Barr virus infection.

Authors:  Marika Valota; Friedrich Thienemann; Benjamin Misselwitz
Journal:  BMJ Case Rep       Date:  2019-05-10

2.  Natural Mosquito-Pathogen Hybrid IgG4 Antibodies in Vector-Borne Diseases: A Hypothesis.

Authors:  Berlin Londono-Renteria; Jenny C Cardenas; Andrea Troupin; Tonya M Colpitts
Journal:  Front Immunol       Date:  2016-09-29       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.